U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  FORM 10-QSB  x
        QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGE ACT OF 1934  For the quarterly period ended November 30, 2005  o
        TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGE ACT OF 1934  For the transition period from  Commission File No. 000-50817  ORGRAL TECHNOLOGIES CORP. (Exact name of small business issuer as specified in its charter)  Delaware(State or other jurisdiction of
incorporation or organization)
        (I.R.S. Employer Identification No.)  113 Argonne Crescent, Toronto, Ontario M2K 2K2 (Address of Principal Executive Offices)  (416) 557-9684 (Issuers telephone number)  330 Highway 7 East, Suite 511 Richmond Hill, Ontario L4B 3P8 (Former name, address and fiscal year, if changed since last report)  Check whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the issuer was required to file such reports), and (2)has been subject to such filing requirements for the past 90 days. Yesx
        Noo  Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. YesxNoo  State the number of shares outstanding of each of the issuers classes of common equity, as of January 23, 2006: 100,000 shares of common stock.     ORGRAL TECHNOLOGIES CORP. .

FINANCIAL STATEMENTS



INDEX



Part I-- FINANCIAL INFORMATION




Item 1. Financial Statements


Item 2. Managements Discussion and Analysis of Financial Condition


Item 3. Control and Procedures

Part II-- OTHER INFORMATION




Item 1. Legal Proceedings


Item 2. Changes in Securities


Item 3. Defaults Upon Senior Securities


Item 4. Submission of Matters to a Vote of Security Holders


Item 5. Other Information


Item 6. Exhibits and Reports on Form 8-K

Signature










Item 1. Financial Information



BASIS OF PRESENTATION



The accompanying reviewed financial statements are presented in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-QSB and item 310 under subpart A of Regulation S-B. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of normal occurring accruals) considered necessary in order to make the financial statements not misleading, have been included. Operating results for the six months ended November 30, 2005 are not necessarily indicative of results that may be expected for the year ending May 31, 2006. The financial statements are presented on the accrual basis.










ORGRAL TECHNOLOGIES CORP.

(a development stage company)



FINANCIAL STATEMENTS

(unaudited)







AS OF NOVEMBER 30, 2005





ORGRAL TECHNOLOGIES CORP.

(a development stage company)

Financial Statements Table of Contents








FINANCIAL STATEMENTS
        Page #(unaudited)




Balance Sheet
        F-1




Statement of Operations and Retained Deficit
        F-2/F-3




Statement of Stockholders Equity
        F-4




Cash Flow Statement
        F-5




Notes to the Financial Statements
        F-6














ORGRAL TECHNOLOGIES CORP.

(a development stage company)

BALANCE SHEET

As of November 30, 2005 and May 31, 2005



ASSETS




Nov. 30,
2005
        
        May 31,
2005CURRENT ASSETSCash
        $
        0
        $
        0TOTAL ASSETS
        $
        0
        $
        0LIABILITIES AND STOCKHOLDERS EQUITYCURRENT LIABILITIESAccrued expenses
        $
        2,400
        $
        1,700TOTAL LIABILITIES
        
        2,400
        
        1,700STOCKHOLDERS EQUITYPreferred Stock  par value $0.00110,000,000 shares authorized;None issued and outstanding
        
        0
        
        0Common Stock - par value $0.001;100,000,000 shares authorized;100,000 issued and outstanding
        
        100
        
        100Additional paid in capital
        
        0
        
        0Accumulated Deficit
        
        (2,500)
        
        (1,800)Total stockholders equity
        
        (2,400)
        
        (1,700)TOTAL LIABILITIES AND EQUITY
        $
        0
        $
        0

The accompanying notes are an integral part of these financial statements.



F-1








ORGRAL TECHNOLOGIES CORP.

(a development stage company)

STATEMENT OF OPERATIONS

For the six months ended Nov. 30, 2005, the 160 days ended Nov. 30, 2004

from inception (June 7, 2004) through Nov. 30, 2005






Six Months
Nov. 30, 2005
        
        160 Days
Nov. 30, 2004
        
        From Inception to
Nov. 30, 2005Revenue
        $
        0
        $
        0
        $
        0Cost of Revenue
        
        0
        
        0
        
        0GROSS PROFIT
        
        0
        
        0
        
        0GENERAL AND ADMINISTRATIVE EXPENSES
        
        700
        
        1,100
        
        2,500NET LOSS
        
        (700)
        
        (1,100)
        
        (2,500)ACCUMULATED DEFICIT, BEGINNING BALANCE
        
        (1,800)
        
        0
        
        0ACCUMULATED DEFICIT, ENDING BALANCE
        $
        (2,500)
        $
        (1,100)
        $
        (2,500)NET EARNINGS PER SHARENet loss per share
        
        ($0.03)
        
        ($0.01)Basic Weighted AverageNumber of Common Shares Outstanding
        
        100,000
        
        100,000





The accompanying notes are an integral part of these financial statements.



F-2








ORGRAL TECHNOLOGIES CORP.

(a development stage company)

STATEMENT OF OPERATIONS

For the three months ended Nov. 30, 2005 and 2004






Three Months
        
        Three MonthsNov. 30, 2005
        
        Nov. 30, 2004Revenue
        $
        0
        $
        0Cost of Revenue
        
        0
        
        0GROSS PROFIT
        
        0
        
        0GENERAL AND ADMINISTRATIVE EXPENSES
        
        350
        
        250NET LOSS
        $
        (350)
        $
        (250)



The accompanying notes are an integral part of these financial statements.



F-3




ORGRAL TECHNOLOGIES CORP.

(a development stage company)

STATEMENT OF STOCKHOLDERS EQUITY

From inception(June 7, 2004) through Nov. 30, 2005






SHARES
        
        COMMON
STOCK
        
        ACCUMULATED DEFICIT
        
        TOTALStock issued on acceptanceOf incorporation expensesJune 7, 2004
        100,000
        $
        100
        $
        0
        $
        100Net loss
        
        
        
        
        (1,800)
        
        (1,800)Total at May 31, 2005
        100,000
        $
        100
        $
        (1,800)
        $
        (1,700)Net loss
        
        
        
        
        (700)
        
        (700)Total at November 30, 2005
        100,000
        $
        100
        $
        (2,500)
        $
        (2,400)





The accompanying notes are an integral part of these financial statements.



F-4






ORGRAL TECHNOLOGIES CORP.

(a development stage company)

STATEMENT OF CASH FLOWS

For the six months ended Nov. 30, 2005, the 160 days ended Nov. 30, 2004

from inception (June 7, 2004) through Nov. 30, 2005






Six Months
Nov. 30, 2005
        
        160 days
Nov. 30, 2004
        
        From
InceptionCASH FLOWS FROM OPERATING ACTIVITIESNet income (loss)
        $
        (700)
        $
        (2,050)
        $
        (2,500)Compensation in the form of stock
        
        0
        
        100
        
        100Increases (Decrease) in accrued expenses
        
        700
        
        1,950
        
        2,400NET CASH PROVIDED OR (USED) IN OPERATIONS
        
        0
        
        0
        
        0CASH FLOWS FROM INVESTING ACTIVITIESNone
        
        0
        
        0
        
        0CASH FLOWS FROM FINANCING ACTIVITIESNone
        
        0
        
        0
        
        0CASH RECONCILIATIONNet increase (decrease) in cash
        
        0
        
        0
        
        0Beginning cash balance
        
        0
        
        0
        
        0CASH BALANCE AT END OF PERIOD
        $
        0
        $
        0
        $
        0







The accompanying notes are an integral part of these financial statements.



F-5




ORGRAL TECHNOLOGIES CORP.

NOTES TO FINANCIAL STATEMENTS




1.
        Summary of significant accounting policies:

Industry:



ORGRAL TECHNOLOGIES CORP. (the Company), a Company incorporated in the state of  Delaware as of June 7, 2004, plans to locate and negotiate with a business  entity for the combination of that target company with The Company. The  combination will normally take the form of a merger, stock-for-stock exchange or  stock- for-assets exchange. In most instances the target company will wish to  structure the business combination to be within the definition of a tax-free  reorganization under Section 351 or Section 368 of the Internal Revenue Code of  1986, as amended. No assurances can be given that The Company will be successful  in locating or negotiating with any target company.



The Company has been formed to provide a method for a foreign or domestic  private company to become a reporting (public) company whose securities are  qualified for trading in the United States secondary market.



The Company has adopted its fiscal year end to be May 31.



Results of Operations and Ongoing Entity:



The  Company  is  considered  to  be  an  ongoing  entity.   The  Companys
shareholders fund any shortfalls in The Companys cash flow on a day to day
basis  during the time  period  that The  Company is in the  development  stage.



Liquidity and Capital Resources:



In addition to the stockholder funding capital shortfalls; The Company   anticipates interested investors that intend to fund the Companys growth   once a business is located.



Cash and Cash Equivalents:



The Company considers cash on hand and amounts on deposit with financial   institutions which have original maturities of three months or less to be   cash and cash equivalents.

Basis of Accounting:



The Companys financial statements are prepared in accordance with  generally accepted accounting principles.



Income Taxes:



The Company utilizes the asset and liability method to measure  and record deferred income tax assets and liabilities. Deferred tax assets and  liabilities reflect the future income tax effects of temporary differences  between the financial statement carrying amounts of existing assets and  liabilities and their respective tax bases and are measured using enacted tax  rates that apply to taxable income in the years in which those temporary  differences are expected to be recovered or settled. Deferred tax assets are  reduced by a valuation allowance when in the opinion of management, it is more  likely than not that some portion or all of the deferred tax assets will not be  realized. At this time, the Company has set up an allowance for deferred taxes  as there is no company history to indicate the usage of deferred tax assets and  liabilities.



F-6




ORGRAL TECHNOLOGIES CORP.

NOTES TO FINANCIAL STATEMENTS



Fair Value of Financial Instruments:



The Companys financial instruments may include cash and cash equivalents,   short-term investments, accounts receivable, accounts payable and liabilities   to banks and shareholders. The carrying amount of long-term debt to banks   approximates fair value based on interest rates that are currently available   to the Company for issuance of debt with similar terms and remaining maturities.  The carrying amounts of other financial instruments approximate their fair   value because of short-term maturities.



Concentrations of Credit Risk:



Financial instruments which potentially expose the Company to concentrations   of credit risk consist principally of operating demand deposit accounts.  The Companys policy is to place its operating demand deposit accounts with   high credit quality financial institutions. At this time the Company has no   deposits that are at risk.




2.
        Related Party Transactions and Going Concern:

The Companys financial statements have been presented on the basis that it is a  going concern in the development stage, which contemplates the realization of  assets and the satisfaction of liabilities in the normal course of business. At  this time the Company has not identified the business that it wishes to engage  in.



The Companys shareholders fund the Companys activities while The Company takes  steps to locate and negotiate with a business entity for combination; however,  there can be no assurance these activities will be successful.




3.
        Accounts Receivable and Customer Deposits:

Accounts receivable and Customer deposits do not exist at this time and therefore have no allowances accounted for or disclosures made.




4.
        Use of Estimates:

Management uses estimates and assumptions in preparing these financial  statements in accordance with generally accepted accounting principles. Those  estimates and assumptions affect the reported amounts of assets and liabilities,  the disclosure of contingent assets and liabilities, and the reported revenue  and expenses. Management has no reason to make estimates at this time.




5.
        Revenue and Cost Recognition:

The Company uses the accrual basis of accounting in accordance with generally accepted accounting principles for financial statement reporting.




6.
        Accrued Expenses:

Accrued expenses consist of accrued legal, accounting and office costs during this stage of the business.




7.
        Operating Lease Agreements:

The Company has no agreements at this time.



F-7




ORGRAL TECHNOLOGIES CORP.

NOTES TO FINANCIAL STATEMENTS




8.
        Stockholders Equity:

PREFERRED STOCK includes 10,000,000 shares authorized at a par value of $0.001, of which no shares have been issued.



COMMON STOCK includes 100,000,000 shares authorized at a par value of $0.001, of  which 100,000 have been issued for the amount of $100 on June 7, 2004 in  acceptance of the incorporation expenses for the Company.




9.
        Required Cash Flow Disclosure for Interest and Taxes Paid:

The company has paid no amounts for federal income taxes and interest. The  Company issued 100,000 common shares of stock to its sole shareholder in  acceptance of the incorporation expenses for the Company.




10.
        Earnings Per Share:

Basic earnings per share (EPS) is computed by dividing earnings available to  common shareholders by the weighted-average number of common shares outstanding  for the period as required by the Financial Accounting Standards Board (FASB)  under Statement of Financial Accounting Standards (SFAS) No. 128, Earnings per  Shares. Diluted EPS reflects the potential dilution of securities that could  share in the earnings.







F-8




Item 2. Managements Discussion and Analysis of Financial Conditions and Results of Operations



Plan of Operation



The Registrant is continuing its efforts to locate a merger candidate for the purpose of a merger. It is possible that the registrant will be successful in locating such a merger candidate and closing such merger. However, if the registrant cannot effect a non-cash acquisition, the registrant may have to raise funds from a private offering of its securities under Rule 506 of Regulation D. There is no assurance the registrant would obtain any such equity funding.



Results of Operation



The Company did not have any  operating  income  from  inception  (June 7, 2004)
through  November  30,  2005.  For the quarter  ended  November  30,  2005,  the
registrant  recognized  a net  loss of $700.  Some  general  and  administrative
expenses  during the year were accrued.  Expenses for the quarter were comprised
of costs mainly associated with legal and accounting fees.



Liquidity and Capital Resources



At November 30, 2005 the Company had no capital resources and will rely upon the issuance of common stock and additional capital contributions from shareholders to fund administrative expenses pending acquisition of an operating company.



Item 3. Controls and Procedures



(a) Evaluation of disclosure controls and procedures.



Our Chief Executive Officer and Chief Financial Officer (collectively the Certifying Officers) maintain a system of disclosure controls and procedures that is designed to provide reasonable assurance that information, which is required to be disclosed, is accumulated and communicated to management timely. Under the supervision and with the participation of management, the Certifying Officers evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule [13a-14(c)/15d-14(c)]under the Exchange Act) within 90 days prior to the filing date of this report. Based upon that evaluation, the Certifying Officers concluded that our disclosure controls and procedures are effective in timely alerting them to material information relative to our company required to be disclosed in our periodic filings with the SEC.



(b) Changes in internal controls.



Our Certifying Officer has indicated that there were no significant changes in our internal controls or other factors that could significantly affect such controls subsequent to the date of his evaluation, and there were no such control actions with regard to significant deficiencies and material weaknesses.








PART II - OTHER INFORMATION




Item 1.
        Legal Proceedings.

The Company is currently not a party to any pending legal proceedings and no such action by, or to the best of its knowledge, against the Company has been threatened.




Item 2.
        Changes in Securities.


None


Item 3.
        Defaults Upon Senior Securities.


None


Item 4.
        Submission of Matters to a Vote of Security Holders.

No matter was submitted during the quarter ending November 30, 2005, covered by this report to a vote of the Companys shareholders, through the solicitation of proxies or otherwise.




Item 5.
        Other Information.


None


Item 6.
        Exhibits and Reports of Form 8-K.


(a) Exhibits


31.1 Certification pursuant to Section 302 of Sarbanes Oxley Act of 2002


32.1 Certification pursuant to Section 906 of Sarbanes Oxley Act of 2002


(b) Reports of Form 8-K


None










SIGNATURES



In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, there unto duly authorized.




ORGRAL TECHNOLOGIES CORP.Registrant




Date: January 23, 2006
        
        By: /s/ Helen HeitHelen HeitPresident